GSK offloads two vaccines in $1.1B deal as it works to revive the pipeline
GlaxoSmithKline is leaving the deep dark woods and its viruses behind.
GSK has agreed to divest its vaccines for rabies, RabAvert, and tick-born encephalitis vaccine …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
